Product
Recombinant human glutamic acid decarboxylase (rhGAD65)
1 clinical trial
1 indication
Indication
Type 1 Diabetes MellitusClinical trial
A Phase III, Randomized, Double-blind, Placebo-controlled, Multicenter Trial to Evaluate the Efficacy and Safety of Diamyd® to Preserve Endogenous Beta Cell Function in Adolescents and Adults With Recently Diagnosed Type 1 Diabetes, Carrying the Genetic HLA DR3-DQ2 HaplotypeStatus: Recruiting, Estimated PCD: 2025-12-31